Multimeric forms of antimicrobial peptides

Patent metadata

Field	Value
Publication number	US-9220264-B2
Application number	US-201314090057-A
Country	US
Kind code	B2
Filing date	Nov 26, 2013
Priority date	Apr 21, 2008
Publication date	Dec 29, 2015
Grant date	Dec 29, 2015

Abstract

The invention relates to multimeric forms of antimicrobial peptides, for example, defensin peptides. The multimeric forms of defensin peptides possesses antimicrobial activity and may be formulated into antimicrobial compositions, pharmaceutical compositions, eyedrop composition, contact lens solution compositions for coating medical devices and the like. The invention also relates to the use of these multimeric forms of peptides, e.g. multimeric forms of defensin peptides for inhibiting and/or reducing the growth of microorganisms in general, including in a host. The invention further relates to a method of preparing multimers of peptides derived from defensins, for example hBD3. The method includes a composition or combination comprising the multimeric antimicrobial peptides and at least one active pharmaceutical ingredient.

First claim

The invention claimed is:

1. A composition or a combination comprising at least one multimer comprising the formula (U) 2 KK, wherein U comprises SEQ ID NO: 2-53 or 57-59; and at least one other active pharmaceutical ingredient.

2. The composition or combination according to claim 1 , wherein U comprises SEQ ID NO: 36.

3. The composition or combination according to claim 1 , wherein U comprises SEQ ID NO: 44.

4. The composition or combination according to claim 1 , wherein the active pharmaceutical ingredient comprises an antimicrobial compound.

5. The composition or combination according to claim 4 , wherein the antimicrobial compound is selected from the group consisting of chloramphenicol, penicillins, macrolides, fluoroquinolones, aminoglycosides, β-lactams or quinolones.

6. The composition or combination according to claim 1 , comprising (SEQ ID NO: 44) 2 KK and at least one antimicrobial compound selected from the group consisting of chloramphenicol, penicillins, macrolides, fluoroquinolones, aminoglycosides, β-lactams and quinolones.

7. The composition or combination according to claim 1 , comprising (SEQ ID NO: 44) 2 KK and at least one antimicrobial compound selected from the group consisting of carbenicillin, chloramphenicol, erythromycin, gatifloxacin, gentamycin, imipenam, kanamycin, nalidixic acid or streptomycin.

8. The composition or combination according to claim 1 , comprising (SEQ ID NO: 44) 2 KK and gatifloxacin.

9. The composition or combination according to claim 1 , wherein the multimer and the antimicrobial compound acts synergistically.

10. A method of treating at least one microbial infection comprising administering to a subject at least one multimer comprising the formula (U) 2 KK, wherein U comprises SEQ ID NO: 2 -53 or 57-59; and at least one other active pharmaceutical ingredient.

11. The method according to claim 10 , wherein U comprises SEQ ID NO: 36.

12. The method according to claim 10 , wherein U comprises SEQ ID NO: 44.

13. The method according to claim 10 , wherein the active pharmaceutical ingredient comprises an antimicrobial compound.

14. The method according to claim 10 , wherein U comprises SEQ ID NO: 44 and the antimicrobial compound comprises carbenicillin, chloramphenicol, erythromycin, gatifloxacin, gentamycin, imipenam, kanamycin, nalidixic acid or streptomycin.

15. The method according to claim 11 , wherein the multimer and the active pharmaceutical ingredient are administered separately.

16. The method according to claim 11 , wherein the multimer and the active ingredient are administered together.

17. The method according to claim 10 , wherein the multimer and the active pharmaceutical ingredient act synergistically.

18. A method of inhibiting and/or reducing the growth of microorganisms comprising contacting at least one microorganism with at least one isolated multimer comprising the formula (U) 2 KK, wherein U comprises SEQ ID NO: 2-53 or 57-59; and at least one other antimicrobial compound.

Assignees

• Singapore Health Serv Pte Ltd
• Agency Science Tech & Res

Inventors

• Beuerman Roger W
• Liu Shouping
• Li Jing
• Zhou Lei
• Verma Chandra Shekhar
• Tan Donald

Classifications

• A61K2300/00

  Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00 · CPC title

• A61K31/496

  Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin · CPC title

• A61K38/16

  Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof {(enzyme inhibitors A61K38/005)} · CPC title

• C07K14/4723

  Cationic antimicrobial peptides, e.g. defensins · CPC title

• A61K38/04

  Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof ({enzyme inhibitors A61K38/005;} gastrins {A61K38/2207}, somatostatins A61K38/31, melanotropins A61K38/34 {; protease inhibitors A61K38/55}) · CPC title